CORPORATE UNIVERSE INC [COUV] Filings

10-Q 1 couv_10q.htm FORM 10-Q couv_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended SEPTEMBER 30, 2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from _______________________to___________________________

Commission File Number: 000-56271

CORPORATE UNIVERSE, INC.

(Exact name of registrant as specified in its charter)

Delaware		85-2005645
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2093 Philadelphia Pike #8334, Claymont, DE		19703
(Address of principal executive offices)		(Zip Code)

(302) 273-1150

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of each exchange on which registered
Not applicable		Not applicable		Not applicable

The number of shares outstanding of the registrant’s common stock, par value of $0.0001, on November 15, 2023 was 625,068,420.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION		3
ITEM 1.	Financial Statements	3
ITEM 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	4
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	10
ITEM 4.	Controls and Procedures	10
PART II—OTHER INFORMATION		12
ITEM 1.	Legal Proceedings	12
ITEM 1A.	Risk Factors	12
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	12
ITEM 3.	Defaults upon senior securities	12
ITEM 4.	mine safety disclosures	12
ITEM 5.	other information	12
ITEM 6.	exhibits	12
SIGNATURES		13

Page 2 of 13

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Financial Statements

Corporate Universe, Inc.

		Page
Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022		F-1

Consolidated Statements of Operations and Comprehensive Loss (unaudited) for the three and nine months ended September 30, 2023 and 2022		F-2

Consolidated Statements of Stockholders’ Deficit (unaudited) for the three and nine months ended September 30, 2023		F-3

Consolidated Statements of Stockholders’ Deficit (unaudited) for the three and nine months ended September 30, 2022		F-4

Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2023 and 2022		F-5

Notes to the Unaudited Consolidated Financial Statements		F-6

Page 3 of 13

Table of Contents

CORPORATE UNIVERSE, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

	September 30,			December 31,
	2023			2022
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	475,687		$	464,227
Inventory		103,819			101,745
Landlord buildout refund receivable		-			109,725
Prepaid expenses		67,092			23,421
Income tax credits receivable		174,187			-
TOTAL CURRENT ASSETS		820,785			699,118
FIXED ASSETS
Property and equipment		802,030			775,001
TOTAL FIXED ASSETS		802,030			775,001
OTHER ASSETS
Intellectual property, net of impairment		550,504			528,357
Security deposits		49,398			48,411
Right-of-use assets, net of accumulated amortization		277,574			368,615
TOTAL OTHER ASSETS		877,476			945,383
TOTAL ASSETS	$	2,500,291		$	2,419,502

LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	634,581		$	819,640
Payroll taxes payable		149,325			386,001
Due to stockholders		824,893			610,908
Note payable related party		585,000			585,000
Notes payable		2,375,864			851,761
Current portion of operating lease liabilities		119,609			129,416
Convertible notes payable		196,500			206,500
TOTAL CURRENT LIABILITIES		4,885,772			3,589,226
Operating lease liabilities, net of current portion		183,747			271,808
TOTAL LIABILITIES		5,069,519			3,861,034

Commitments and contingencies (Note 14)

STOCKHOLDERS' DEFICIT
Preferred Stock, $.0001 par value, 1,000,000 shares authorized
Series E: 81,100 authorized, 81,032 issued and outstanding		8			8
Series F: 100,000 authorized, 100,000 issued and outstanding		10			10
Series G: 25 authorized, 20 shares issued and outstanding		-			-
Series C: 100,000 authorized, 0 shares issued and outstanding		-			-
Series D: 100,000 authorized, 100,000 issued and outstanding		10			10
Common stock, $.0001 par value, 2,500,000,000 shares authorized, 625,068,420 and 568,849,670 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively		62,507			56,885
Additional paid-in-capital		4,862,149			3,743,396
Accumulated deficit		(7,350,085	)		(5,132,013	)
Cumulative translation adjustment		(143,827	)		(109,828	)
TOTAL STOCKHOLDERS' DEFICIT		(2,569,228	)		(1,441,532	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	2,500,291		$	2,419,502

(See accompanying notes to the unaudited consolidated financial statements)

F-1

Table of Contents

CORPORATE UNIVERSE, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

	For the three months						For the nine months
	ended September 30,						ended September 30,
	2023			2022			2023			2022

SALES	$	-		$	-		$	-		$	-
COST OF SALES		-			-			-			-
GROSS PROFIT		-			-			-			-

OPERATING EXPENSES
Officers' salaries		90,194			186,598			247,987			554,551
Salaries and wages		110,488			77,064			415,626			380,428
Payroll taxes		26,998			76,830			50,810			122,699
Legal and professional fees		176,486			296,055			565,028			805,521
General and administrative expenses		30,356			35,992			312,321			328,509
TOTAL OPERATING EXPENSES		434,522			672,539			1,591,772			2,191,708

OPERATING LOSS		(434,522	)		(672,539	)		(1,591,772	)		(2,191,708	)

OTHER INCOME (EXPENSES)
Interest income		-			197			-			197
Loss on impairment of intellectual property		(12,737	)		-			(85,938	)		-
Interest expense		(392,876	)		(35,195	)		(717,780	)		(44,290	)
LOSS BEFORE INCOME TAX CREDITS		(840,135	)		(707,537	)		(2,395,490	)		(2,235,801	)

Income tax credits		55,669			56,401			177,418			238,714

NET LOSS		(784,466	)		(651,136	)		(2,218,072	)		(1,997,087	)

OTHER COMPREHENSIVE LOSS
Foreign currency translation adjustment		(1,432	)		(135	)		(117,587	)		(137,441	)

COMPREHENSIVE LOSS	$	(785,898	)	$	(651,271	)	$	(2,335,659	)	$	(2,134,528	)

LOSS PER COMMON SHARE:
Basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE NUMBER OF COMMON SHARES:
Basic and diluted		606,318,420			551,537,170			586,834,045			550,549,670

(See accompanying notes to the unaudited consolidated financial statements)

F-2

Table of Contents

CORPORATE UNIVERSE, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

(Unaudited)

									Additional					Cumulative
	Preferred Stock				Common Stock				Paid-In		Accumulated			Translation
	Shares		Amount		Shares		Amount		Capital		Deficit			Adjustment			Total

Balance, December 31, 2022		281,052	$	28		568,849,670	$	56,885	$	3,743,396	$	(5,132,013	)	$	(109,828	)	$	(1,441,532	)

Issuance of common stock related to debt		-		-		7,125,000		713		141,787		-			-			142,500

Foreign currency translation adjustment		-		-		-		-		-		-			(14,759	)		(14,759	)

Net loss		-		-		-		-		-		(651,405	)		-			(651,405	)

Balance, March 31, 2023		281,052		28		575,974,670		57,598		3,885,183		(5,783,418	)		(124,587	)		(1,965,196	)

Issuance of common stock related to debt		-		-		11,593,750		1,159		230,716		-			-			231,875

Foreign currency translation adjustment		-		-		-		-		-		-			23,528			23,528

Net loss		-		-		-		-		-		(782,201	)		-			(782,201	)

Balance, June 30, 2023		281,052		28		587,568,420		58,757		4,115,899		(6,565,619	)		(101,059	)		(2,491,994	)

Issuance of common stock related to debt		-		-		37,500,000		3,750		746,250		-			-			750,000

Foreign currency translation adjustment		-		-		-		-		-		-			(42,768	)		(42,768	)

Net loss		-		-		-		-		-		(784,466	)		-			(784,466	)

Balance, September 30, 2023		281,052	$	28		625,068,420	$	62,507	$	4,862,149	$	(7,350,085	)	$	(143,827	)	$	(2,569,228	)

(See accompanying notes to the unaudited consolidated financial statements)

F-3

Table of Contents

CORPORATE UNIVERSE, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

(Unaudited)

											Additional					Cumulative
	Preferred Stock				Common Stock						Paid-In		Accumulated			Translation
	Shares		Amount		Shares			Amount			Capital		Deficit			Adjustment			Total

Balance, December 31, 2021		281,052	$	28		533,549,670		$	53,355		$	2,292,427	$	(2,976,773	)	$	20,963		$	(610,000	)

Issuance of common stock		-		-		24,800,000			2,480			989,520		-			-			992,000

Issuance of Series G preferred stock		-		-		-			-			7,500		-			-			7,500

Foreign currency translation adjustment		-		-		-			-			-		-			(47,748	)		(47,748	)

Net loss		-		-		-			-			-		(559,336	)		-			(559,336	)

Balance, March 31, 2022		281,052		28		558,349,670			55,835			3,289,447		(3,536,109	)		(26,785	)		(217,584	)

Issuance of common stock		-		-		1,625,000			163			64,837		-			-			65,000

Issuance of Series G preferred stock		-		-		(10,000,000	)		(1,000	)		1,000		-			-			-

Foreign currency translation adjustment		-		-		-			-			-		-			(92,545	)		(92,545	)

Net loss		-		-		-			-			-		(786,615	)		-			(786,615	)

Balance, June 30, 2022		281,052		28		549,974,670			54,998			3,355,284		(4,322,724	)		(119,330	)		(1,031,744	)

Issuance of common stock		-		-		3,125,000			313			124,687		-			-			125,000

Foreign currency translation adjustment		-		-		-			-			-		-			(175,719	)		(175,719	)

Net loss		-		-		-			-			-		(651,136	)		-			(651,136	)

Balance, September 30, 2022		281,052	$	28		553,099,670		$	55,311		$	3,479,971	$	(4,973,860	)	$	(295,049	)	$	(1,733,599	)

(See accompanying notes to the unaudited consolidated financial statements)

F-4

Table of Contents

CORPORATE UNIVERSE, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the nine months ended September 30,
	2023			2022
Cash flows from operating activities:
Net loss	$	(2,218,072	)	$	(1,997,087	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of right-of-use assets		91,041			90,043
Amortization of note payable discount		524,728			11,125
Loss on impairment of intellectual property		31,266			-
Changes in operating assets and liabilities:
Inventory		(2,074	)		19,848
Landlord buildout refund receivable		109,725			-
Prepaid expenses		(43,671	)		56,219
Income tax credits receivable		(174,187	)		402,614
Security deposit		(987	)		9,444
Accounts payable and accrued expenses		(185,059	)		296,088
Payroll taxes payable		(236,676	)		153,981
Operating lease liabilities		(97,868	)		(74,115	)
Net cash used in operating activities		(2,201,834	)		(1,031,840	)
Cash flows from investing activities:
Acquisition of property and equipment		(27,029	)		(599,990	)
Addition to intellectual property		(53,413	)		(47,454	)
Net cash used in investing activities		(80,442	)		(647,444	)
Cash flows from financing activities:
Advances from stockholders		213,985			241,945
(Repayment of) Proceeds from convertible note		(10,000	)		175,000
Proceeds from notes payable		999,375			479,961
Proceeds from the issuance of common stock		1,124,375			1,182,000
Proceeds from the issuance of preferred stock		-			7,500
Net cash provided by financing activities		2,327,735			2,086,406
Effect of exchange rate changes on cash		(33,999	)		(316,012	)
Net increase in cash		11,460			91,110
Cash at beginning of the period		464,227			3,208
Cash at end of the period	$	475,687		$	94,318

Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	27,710		$	-
Income taxes	$	-		$	-

(See accompanying notes to the unaudited consolidated financial statements)

F-5

Table of Contents

Corporate Universe, Inc. and Subsidiary

Notes to Unaudited Consolidated Financial Statements

For The Three and Nine Months Ended September 30, 2023

(1) Organization and Business Description

Corporate Universe, Inc. ("COUV”) was incorporated in Delaware on May 28, 1986. On July 17, 2020, the Company changed its name from Carrier Alliance Group Inc. to Corporate Universe, Inc.

The accompanying unaudited consolidated financial statements include COUV and its wholly-owned subsidiary Carbon-Ion Energy, Inc. (“CIE”), which includes its wholly owned subsidiary Oxcion Limited (“OXC”) (collectively, the “Company”).

CIE was incorporated under the laws of the State of Delaware on December 29, 2020 and operates as a holding company for OXC, which was incorporated under the laws of England and Wales on February 20, 2009. OXC operated as a business consulting entity until December 31, 2020. Effective March 11, 2021, OXC became a wholly-owned subsidiary of CIE pursuant to a share exchange agreement whereby the existing stockholders of OXC received the same pro-rata equity interests in CIE. Going forward, OXC plans to market its patented super capacitor technology to customers worldwide.

Effective November 12, 2021, CIE became a wholly-owned subsidiary of COUV pursuant to a share exchange agreement whereby the existing stockholders of CIE obtained control of COUV. The transaction was accounted for as a change in control with COUV being considered the accounting acquired company and CIE being considered the accounting acquirer. The fiscal year end of the consolidated Company is December 31st.

(2) Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The accompanying unaudited consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash

For financial statement presentation purposes, the Company considers all short-term investments with an original maturity date of three months or less to be cash equivalents.

Inventory

Inventory, which consists substantially of raw materials, is stated at the lower of cost (first-in, first-out basis) or market (net realizable value). The inventory is valued at the end of each fiscal period for the purpose of determining if a reserve for obsolescence needs to be recorded. There is no reserve for obsolescence as of September 30, 2023 and December 31, 2022.

F-6

Table of Contents

Property and Equipment

Property and equipment is stated at cost. Maintenance and repairs are expensed as incurred. Upon sale or disposition of assets, any gain or loss is included in the consolidated statements of operations. The cost of property and equipment is depreciated using the straight-line method over the estimated useful lives of the assets when placed in service, which range from three to seven years.

Income Taxes

The Company has adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740-10, “Accounting for Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits as a component of general and administrative expenses. The Company’s federal tax return and any state tax returns are not currently under examination.

OXC accrues research and development (“R&D”) tax credits receivable from the HM Revenue and Customs (“HMRC”) in England based on 14.50% of qualified R&D payroll costs. OXC, at its sole discretion, can elect to forego the tax credit and carry forward the qualified R&D payroll costs to offset future taxable income in England.

Intellectual Property

The Company’s intangible assets consist of patents on its technology, recorded at cost. Cost is based on third party expenditures for patent acquisitions and applications. OXC will begin amortizing the intangibles over their estimated remaining useful life when they commence revenue-producing activities. OXC will determine the useful lives of its intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors that will be considered when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the long-term strategy for using the asset, any laws or other local regulations that could impact the useful life of the asset, and other economic factors, including competition and specific market conditions.

Impairment of Long-lived Assets

Potential impairments of long-lived assets are reviewed when events or changes in circumstances indicate a potential impairment may exist. In accordance with FASB ASC 360-10, “Property, Plant and Equipment - Overall,” impairment is determined when estimated future undiscounted cash flows associated with an asset are less than the asset’s carrying value. The reserve for impairment for obsolescence as of September 30, 2023 and December 31, 2022 was $271,875 and $240,609, respectively.

Revenue Recognition

The Company recognizes revenue in accordance with FASB ASC 606, “Revenue from contracts with customers.” Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

F-7

Table of Contents

The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of FASB ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company expects to recognize revenues as the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied.

Stock Based Compensation Expense

The Company records stock-based compensation in accordance with the provisions of FASB ASC 718, “Accounting for Stock Compensation,” which establishes accounting standards for transactions in which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under FASB ASC Topic 718, the Company recognizes an expense for the fair value of its stock awards at the time of grant and the fair value of its outstanding stock options as they vest, whether held by employees or others. As of September 30, 2023 and December 31, 2022, there were no options outstanding.

Convertible Debentures

The Company adopted the guidance in Accounting Standards Updated (“ASU”) 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity on January 1, 2022. ASU 2020-06 simplifies an issuer’s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. Additionally. ASU 2020-06 removes the requirements for accounting for beneficial conversion features. The Company adopted ASU 2020-06 utilizing the modified retrospective method, which resulted in an immaterial impact to the Company.

Leases

The Company accounts for leases in accordance with FASB ASC 842, “Leases”. Based on this standard, the Company determines if an agreement is a lease at inception. Operating leases are included in right-of-use assets, current portion of operating lease liabilities, and operating lease liabilities in the Company’s unaudited consolidated balance sheets. Finance leases are included in property and equipment, current portion of long-term debt, and long-term debt in the Company’s unaudited consolidated balance sheets.

As permitted under FASB ASC 842, the Company has made an accounting policy election not to apply the recognition provisions to short term leases (leases with a lease term of twelve months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term. The Company did not have any short-term leases as of September 30, 2023 and December 31, 2022.

Foreign Currency Translation

Assets and liabilities of CIE’s United Kingdom subsidiary are translated from pounds sterling to United States dollars at the exchange rate in effect as of the consolidated balance sheet dates. Income and expenses are translated at the average quarterly exchange rates in effect for each reporting period. The translation adjustments for reporting periods are included in the Company’s consolidated statements of operations and comprehensive loss, and the cumulative effect of such adjustments are reported in the Company’s balance sheets as a cumulative translation adjustment within stockholders’ deficit.

F-8

Table of Contents

Net Income (Loss) Per Common Share

The Company computes loss per common share, in accordance with FASB ASC 260, “Earnings Per Share”, which requires dual presentation of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result from the exercise of outstanding stock options, warrants and convertible preferred stock.

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the unaudited consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

(3) Going Concern

As of September 30, 2023, the Company has accumulated operating losses of $7,350,085, has yet to commence operations and has no product sales related to its patented battery storage technology that was acquired on September 11, 2020, all of which raise substantial doubt about its ability to continue as a going concern. The unaudited consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. However, the Company is currently addressing its liquidity issues by continually seeking investment capital through private placement of common stock and debt. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that the Company will be able to complete any additional sales of equity securities or be able to arrange for other financing to fund planned business activities.

(4) Property and Equipment

Property and equipment consisted of the following:

	September 30, 2023		December 31, 2022

Leasehold improvements	$	589,245	$	566,467
Laboratory equipment		211,206		206,986
Other equipment		1,579		1,548
Total	$	802,030	$	775,001

Pursuant to the operating lease agreement for laboratory space in Oxfordshire, England, the leasehold improvements are presented net of the buildout paid by the landlord in the amount of $113,373 and $109,725 as of September 30, 2023 and December 31, 2022, respectively.

Property and equipment has not been placed in service and, as such, there was no depreciation expense for the three and nine months ended September 30, 2023 and 2022.

(5) Intellectual Property

Intellectual property as of September 30, 2023 and December 31, 2022 in the amounts of $550,504 and $528,357 are presented net of impairment reserves of $271,875 and $240,609, respectively. The intellectual property includes various super capacitor technology patents that were acquired on September 11, 2020 as part of the ZapGo Ltd acquisition, plus legal fees subsequently incurred directly related to these patents and additional patent applications. The Company has deferred amortizing the intellectual property until it begins revenue operations in order to more accurately match the expense with the revenue. As such, there was no amortization expense for the three and nine months ended September 30, 2023 and 2022.

F-9

Table of Contents

(6) Operating Lease Right-of-Use Assets and Operating Lease Liabilities

On May 5, 2021, the Company entered into two operating lease agreements for laboratory equipment. The leases ran through April 5, 2023 and May 5, 2023 with monthly rental payments of $1,221 and $605, respectively.

On July 31, 2021, the Company entered into a three-year operating lease agreement for laboratory equipment. The lease runs through July 31, 2024 with monthly rental payments of approximately $4,600, including VAT, plus utilities and a pro-rata share of any joint charges as reasonably determined by the landlord.

On August 2, 2021, the Company entered into a five-year operating lease agreement for laboratory space in Oxfordshire, England. The lease runs through August 2, 2026 with average monthly rental payments of approximately $8,500, including VAT, plus utilities and a pro-rata share of any joint charges as reasonably determined by the landlord.

Operating lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value is the Company’s incremental borrowing rate is estimated to be 10% as the interest rate implicit in most of the Company’s leases is not readily determinable. Operating lease expense is recognized on a straight-line basis over the lease term. The Company recorded $20,182 and $41,753 as operating lease expense for the three months ended September 30, 2023 and 2022, respectively, and $123,559 and $125,259 as operating lease expense for the nine months ended September 30, 2023 and 2022, respectively. Such expense was classified in general and administrative expenses on the consolidated statements of operations and comprehensive loss.

	September 30, 2023			December 31, 2022

Operating leases	$	545,602		$	545,602
Less: accumulated amortization		(268,028	)		(176,987	)
Total	$	277,574		$	368,615

Operating lease liabilities consisted of the following:

	September 30, 2023		December 31, 2022

Current portion	$	119,609	$	129,416
Long-term portion		183,747		271,808
Total	$	303,356	$	401,224

The maturity of lease liabilities for the years ending each December 31st are as follows:

2023	$	38,550
2024		131,700
2025		109,200
2026		63,700
Total		343,150
Less: imputed interest		(39,794	)
Lease liabilities	$	303,356

(7) Payroll Taxes Payable

On August 27, 2021, OXC entered into an installment payment arrangement with HM Revenue & Customs (“HMRC”) in England for the payroll taxes balance due of $364,538 as of June 30, 2021 plus approximately $54,600 for the July payroll tax liability. Payments were to be made in five monthly installments of approximately $76,120 beginning in October 2021 with the final installment due in March 2022 of approximately $38,600 plus any interest due. This final balance was not paid when due and, as such, was added to the additional installment payment arrangement with HMRC dated April 2, 2022.

F-10

Table of Contents

On April 2, 2022, OXC entered into an additional installment payment arrangement with HMRC for payroll taxes liabilities of approximately $277,000, including the $38,600 balance due from the previous installment payment arrangement. Payments were to be made in four monthly installments of approximately $69,250 each beginning in May 2022 through August 2022, but were put on hold while the R&D income tax credits through March 31, 2022 were processed by HMRC. The R&D income tax credits were finalized and remitted to OXC on August 24, 2022 and an updated installment payment arrangement needed to be established with HMRC.

On January 13, 2023, OXC entered into an additional installment payment arrangement with HMRC for payroll taxes liabilities incurred during the year ended December 31, 2022 of approximately $198,000, which is net of R&D income tax credits due from HMRC of approximately $262,000 as of December 31, 2022. The net balance due was paid in four monthly installments of approximately $49,500 each month from February 2023 through May 2023.

Payroll taxes payable as of September 30, 2023 and December 31, 2022 were $149,325 and $386,001, respectively.

(8) Due to Stockholders

Due to stockholders totaled $824,893 and $610,908 as of September 30, 2023 and December 31, 2022, respectively, and consist of funds advanced to CIE for working capital purposes by the President of COUV, who is also a director and stockholder, and the Chief Financial Officer, who is also a director and stockholder. These obligations are unsecured, non-interest bearing, and payable upon demand.

(9) Notes Payable Related Party

On December 31, 2021, CIE executed a promissory note in the amount of $585,000 due to an entity that is beneficially owned and controlled by the President of COUV, who is also a director and stockholder, and received proceeds in the same amount for working capital purposes. This note is unsecured, accrues interest at a rate of 1.9% per annum, and is payable on demand. Principal outstanding in connection with this note totaled $585,000 as of both September 30, 2023 and December 31, 2022. Accrued interest outstanding in connection with this note totaled $19,451 and $11,115 as of September 30, 2023 and December 31, 2022, respectively, which is included within accounts payable and accrued expenses on the consolidated balance sheets. Interest expense in connection with this note totaled $2,779 for the three months ended September 30, 2023 and 2022 and $8,336 for the nine months ended September 30, 2023 and 2022.

(10) Notes Payable

a)	On various dates from February 16 through October 26, 2022, CIE executed a series of promissory notes in amounts totaling $190,000 due to an unrelated third party and received proceeds in the same amount for working capital purposes. These notes are unsecured, accrue interest at rates ranging from 3% to 15% per annum, and have maturity dates ranging from on demand to June 23, 2023 and, effective on that date, two of these promissory notes with principal amounts of $100,000 and $15,000 were formally extended to December 24, 2023 and December 26, 2023, respectively. Principal outstanding in connection with these notes totaled $190,000 as of both September 30, 2023 and December 31, 2022. Accrued interest outstanding in connection with these notes totaled $24,733 and $10,148 as of September 30, 2023 and December 31, 2022, respectively, which is included within accounts payable and accrued expenses on the consolidated balance sheets. Interest expense in connection with these notes totaled $4,915 and $4,595 for the three months ended September 30, 2023 and 2022, respectively, and $14,585 and $5,421 for the nine months ended September 30, 2023 and 2022, respectively

b)	On April 5, 2022, CIE executed a promissory note in the amount of $275,000 due to an unrelated third party and received proceeds of $250,000 for working capital purposes. This note is unsecured, accrues interest at the rate of 15% per annum, and originally matured on May 5, 223 and, effective on that date, was extended to November 5, 2023. The difference of $25,000 was recorded as a debt discount and was amortized to interest expense on a straight-line basis through the original maturity date of the note. Principal outstanding in connection with this note totaled $275,000 as of both September 30, 2023 and December 31, 2022. Accrued interest outstanding in connection with this note totaled $60,914 and $30,061 as of September 30, 2023 and December 31, 2022, respectively, which is included within accounts payable and accrued expenses on the consolidated balance sheets. Interest expense in connection with this note totaled $10,397 for both the three months ended September 30, 2023 and 2022 and $30,853 and $19,664 for the nine months ended September 30, 2023 and 2022, respectively. Amortization of debt discount expense in connection with this note totaled $0 for both the three months ended September 30, 2023 and 2022 and $7,992 and $5,882 for the nine months ended September 30, 2023 and 2022, respectively. The unamortized debt discount in connection with this note was $0 and $7,992 as of September 30, 2023 and December 31, 2022, respectively, which resulted in net promissory note payable balances of $275,000 and $267,008 as of September 30, 2023 and December 31, 2022, respectively.

F-11

Table of Contents

c)	On August 10, 2022, CIE executed a promissory note in the amount of $125,000 due to an unrelated third party and received proceeds in the same amount for working capital purposes. This note was unsecured, accrued interest at the rate of 15% per annum, matured on June 28, 2023, and was paid in full with accrued interest of $27,710 on July 9, 2023. Principal outstanding in connection with this note totaled $0 and $125,000 as of September 30, 2023 and December 31, 2022, respectively. Accrued interest outstanding in connection with this note totaled $0 and $7,346 as of September 30, 2023 and December 31, 2022, respectively, which is included within accounts payable and accrued expenses on the consolidated balance sheets. Interest expense in connection with this note totaled $11,066 and $2,620 for the three months ended September 30, 2023 and 2022, respectively, and $20,364 and $2,620 for the nine months ended September 30, 2023 and 2022, respectively.

d)	On various dates from December 22, 2022 through December 27, 2022, COUV executed a series of promissory notes in various face amounts totaling $530,000 due to unrelated third parties and received proceeds in the same amount for working capital purposes. Additionally, on various dates from January 9, 2023 through March 30, 2023, COUV executed an additional series of promissory notes in various face amounts totaling $285,000 under the same terms and conditions. Additionally, on various dates from April 9, 2023 through September 30, 2023, COUV executed an additional series of promissory notes in various face amounts totaling $463,750 under the same terms and conditions. Finally, on July 27, 2023, COUV executed an additional promissory note in the face amount of $1,500,000 under the same terms and conditions. Collectively, these promissory notes have face values totaling $2,778,750, are unsecured, accrue interest at the rate of 10% per annum, and mature on various dates from December 22, 2023 through July 12, 2024.

	Under the terms of these financings, COUV issued 37,500,000 shares of its common stock during the three months ended September 30, 2023, 11,593,750 shares during the three months ended June 30, 2023, 7,125,000 shares during the three months ended March 31, 2023, and 13,250,000 shares during the three months ended December 31, 2022 for a total of 69,468,750. Such shares were valued at $1,500,000, $463,750, $285,000, and $530,000, respectfully, for a total of $2,778,750 utilizing $0.04 per share based upon COUV’s most recent issuance of common shares in exchange for cash. Therefore, the proceeds from these transactions were allocated equally between the promissory notes and the shares of common stock issued for accounting purposes. This resulted in debt discounts of $750,000 related to the promissory notes issued during the three months ended September 30, 2023, $231,875 related to the promissory notes issued during the three months ended June 30, 2023, $142,500 related to the promissory notes issued during the three months ended March 31, 2023, and $265,000 related to the promissory notes issued during the three months ended December 31, 2022. Such discounts are being amortized to interest expense on a straight-line basis through the maturity dates of the individual notes.

	Principal outstanding in connection with these notes totaled $2,778,750 and $530,000 as of September 30, 2023 and December 31, 2022, respectively. Accrued interest outstanding in connection with these notes totaled $103,234 and $951 as of September 30, 2023 and December 31, 2022, respectively, which is included within accounts payable and accrued expenses on the consolidated balance sheets. Interest expense in connection with these notes totaled $58,944 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $102,282 and $0 for the nine months ended September 30, 2023 and 2022, respectively. Amortization of debt discount expense in connection with these notes totaled $300,046 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $516,735 and $0 for the nine months ended September 30, 2023 and 2022, respectively. The unamortized debt discount in connection with these notes totaled $867,886 and $260,246 as of September 30, 2023 and December 31, 2022, respectively, which resulted in net promissory notes payable balances of $1,910,864 and $269,754 as of September 30, 2023 and December 31, 2022, respectively.

F-12

Table of Contents

(11) Convertible Notes Payable

On various dates from July 26, 2022 through November 29, 2022, CIE executed a series of promissory notes in amounts totaling $206,500 due to unrelated third parties and received proceeds of $199,866 for working capital purposes. The difference of $6,634 relates to transaction fees which were immediately expensed and classified in general and administrative expenses. These notes are unsecured, accrue interest at the rate of 10% per annum, and mature on June 15, 2024. Principal outstanding in connection with these notes totaled $196,500 and $206,500 as of September 30, 2023 and December 31, 2022, respectively. Accrued interest outstanding in connection with these notes totaled $21,999 and $7,374 as of September 30, 2023 and December 31, 2022, respectively. Interest expense in connection with these notes totaled $4,953 and $2,607 for the three months ended September 30, 2023 and 2022, respectively, and $14,625 and $2,607 for the nine months ended September 30, 2023 and 2022, respectively.

These notes will convert into CIE common shares upon the completion of the COUV reorganization and the occurrence of one of the following:

a)	A CIE equity financing of $3,000,000 or more. In this scenario, the notes and accrued interest will convert into shares of CIE common stock at the price per share paid by new investors in such equity financing discounted by 20%.

b)	The maturity of the notes on June 15, 2024. In this scenario, the notes and accrued interest will convert into shares of CIE common stock at a price per share equal to the average of the last reported sales price for each of the ten trading days immediately prior to the maturity date. If the shares of CIE common stock are not listed on a securities exchange at that time, then the fair market value per share shall be determined by the CIE Board of Directors.

(12) Equity

Preferred Stock

The Company has 1,000,000 Shares of Preferred Stock authorized with a par value of $0.0001. The Company has allocated 100,000 Shares for Series C Preferred, 100,000 Shares for Series D Preferred, 81,100 Shares for Series E Preferred, 100,000 Shares for Series F Preferred, and 25 Shares for Series G Preferred.

·	Series E - As of September 30, 2023 and December 31, 2022 there were 81,032 shares issued and outstanding. The Series E Preferred has the following designations:

	·	Convertible at option of holder; each preferred share is convertible into 1,000 common shares.
	·	The holders are entitled to receive dividends if and when declared.
	·	The Series E holders are entitled to receive liquidation in preference to the common holders or any other class or series of preferred stock.
	·	Voting: The Series E Holders are entitled to vote together with the common holders with an amount of votes equal to the amount of shares of common stock into which their shares are convertible, provided that, each Series E Holder will only be able to vote up to 4.99% (or, if the beneficial ownership limitation is increased hereunder, up to 9.99%) of all votes eligible to be cast on any matter to come before the Common Stock shareholder or shareholders generally.

·	Series F - As of September 30, 2023 and December 31, 2022 there were 100,000 shares issued and outstanding. The Series F Preferred has the following designations:

	·	Convertible at option of holder; each preferred share is convertible into $0.25 per share (4,000,000 common shares).
	·	The holders are entitled to receive dividends if and when declared.
	·	The Series F holders are entitled to receive liquidation in preference to the common holders but not above the Series E preferred stock.
	·	Voting: The Series F Holders are entitled to vote together with the common holders with an amount of votes equal to the amount of shares of common stock into which their shares are convertible, provided that, each Series F Holder will only be able to vote up to 4.99% (or, if the beneficial ownership limitation is increased hereunder, up to 9.99%) of all votes eligible to be cast on any matter to come before the Common Stock shareholder or shareholders generally.

F-13

Table of Contents

·	Series G - As of September 30, 2023 and December 31, 2022 there were 19.675 shares issued and outstanding. The Series G Preferred has the following designations:

	·	Each share is convertible at option of holder into 4,000,000 common shares.
	·	The holders are entitled to receive dividends if and when declared.
	·	The Series G holders are entitled to receive liquidation in preference to the common holders and any subsequent issuances of preferred stock.
	·	Voting: The Series G Holders are entitled to vote together with the common holders with an amount of votes equal to the amount of shares of common stock into which their shares are convertible, provided that, each Series G Holder will only be able to vote up to 4.99% (or, if the beneficial ownership limitation is increased hereunder, up to 9.99%) of all votes eligible to be cast on any matter to come before the Common Stock shareholder or shareholders generally.

During the nine months ended September 30, 2022, the Company sold and issued 0.075 shares of Series G Convertible Preferred Stock at $100,000 per share for total proceeds of $7,500.

·	Series C - As of September 30, 2023 and December 31, 2022 there were no Series C shares outstanding. The Series C Preferred has the following designations:

	·	Convertible into common upon the Company completing a reverse stock split upon which the amount converted will equal 20% of the issued and outstanding common shares per the reverse split.
	·	The holders are entitled to receive dividends on par with common on an as converted basis.
	·	In the event of reorganization this Class of Preferred will not be affected by any such capital reorganization.
	·	Voting: The holder of this Series of Preferred shall be entitled to vote representing 20% of the votes eligible to be cast in the matter.

·	·Series D - As of September 30, 2023 and December 31, 2022 there were 100,000 shares issued and outstanding. The Series D Preferred has the following designations:

	·	Each share is convertible at option of holder into 12,938 common shares.
	·	Voting: Each share of the Series D holders is entitled to 12,938 votes on all matters before the common stock shareholders.

The Company has evaluated each series of the Preferred Stock for proper classification under FASB ASC 480 “Distinguishing Liabilities from Equity” and FASB ASC 815 “Derivatives and Hedging”.

FASB ASC 480 generally requires liability classification for financial instruments that are certain to be redeemed, represent obligations to purchase shares of stock or represent obligations to issue a variable number of common shares. The Company concluded that each series of Preferred Stock was not within the scope of FASB ASC 480 because none of the three conditions for liability classification was present.

FASB ASC 815 generally requires an analysis of embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. However, in order to perform this analysis, the Company was first required to evaluate the economic risks and characteristics of each series of the Preferred Stock in its entirety as being either akin to equity or akin to debt. The Company’s evaluation concluded that each series of Preferred Stock was more akin to an equity-like contract largely due to the fact the financial instrument is not mandatorily redeemable for cash and the holders are not entitled to any dividends. Other features of the Preferred Stock that operate like equity, such as the conversion option and voting feature, afforded more evidence, in the Company’s view, that the instrument is more akin to equity. As a result, the embedded conversion features are clearly and closely related to their equity host instruments. Therefore, the embedded conversion features do not require bifurcation and classification as derivative liabilities.

Common Stock

The Company has 2,500,000,000 shares of Common Stock authorized with a par value of $0.0001. As of September 30, 2023 and December 31, 2022 there were 625,068,420 and 568,849,670 shares issued and outstanding, respectively.

During the nine months ended September 30, 2022, the Company issued 26,425,000 shares of restricted common stock to unrelated third parties in a series of private placements at $0.04 per share for total proceeds of $1,057,000.

During the quarters ended December 31, 2022, March 31, 2023, June 30, 2023, and September 30, 2023 and as further described in Note 10(d), Notes Payable, the Company issued 13,250,000, 7,125,000, 11,593,750, and 37,500,000 shares, respectively, an aggregate of 69,468,750 shares, of restricted common stock in connection with the issuance of a series of notes payable to unrelated third parties with total proceeds of $2,778,750. Such proceeds were allocated equally between the notes and the shares of common stock issued for accounting purposes. This resulted in an allocation to common stock of $0.02 per share for total proceeds of $1,389,375.

F-14

Table of Contents

During the quarters ended December 31, 2022, March 31, 2023, June 30, 2023, and September 30, 2023 we issued 13,250,000, 7,125,000, 11,593,750, and 37,500,000 shares of our common stock in connection with the issuance of promissory notes to unrelated third parties totaling $2,778,750 for working capital purposes and received proceeds of the same amount. A portion of such proceeds, $1,389,375, was allocated to the issuance of those 69,468,750 shares. Those issuances were exempt under Section 4(a)(2) of the Securities Act of 1933, as amended.

(13) Income Taxes

As of September 30, 2023 and December 31, 2022, the Company had net operating loss carry forwards of approximately $7,350,085 and $5,132,000 that may be available to reduce future years’ taxable income in varying amounts through 2038. Future tax benefits which may arise as a result of these losses have not been recognized in these unaudited consolidated financial statements, as their realization is determined not likely to occur and, accordingly, the Company has recorded a full valuation allowance equal to the deferred tax asset relating to these tax loss carry-forwards of approximately $1,544,000 and $1,078,000 as of September 30, 2023 and December 31, 2022, respectively.

The Company periodically evaluates the likelihood of the realization of deferred tax assets and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors.

Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations and comprehensive loss. There were no interest or penalties accrued as of September 30, 2023 or December 31, 2022.

The Company recorded R&D income tax credits in the amounts of $55,669 and $56,401 for the three months ended September 30, 2023 and 2022, respectively, and $177,418 and $238,714 for the nine months ended September 30, 2023 and 2022, respectively. The balances due from the HMRC for these R&D income tax credits totaled $174,187 and $0 as of September 30, 2023 and December 31, 2022, respectively.

(14) Commitments and Contingencies

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, “Contingencies”. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of September 30, 2023, the Company is not aware of any contingent liabilities that should be reflected in the unaudited consolidated financial statements.

F-15

Table of Contents

On March 31, 2021, CIE entered into an Employment Agreement (the “Agreement”) with the Chief Executive Officer (“CEO”), who is also a director, for an initial term of one year with a base salary of $465,000 per annum paid in equal monthly installments, less applicable withholdings and deductions as required by law. The Company shall review the base salary on an annual basis and has the right, but not the obligation, to increase it, but has no right to decrease the base salary. This Agreement automatically extends for additional terms of one year unless either party provided at least six months prior written notice of non-renewal during the initial term or the then current renewal term. In addition, the CEO is entitled to receive an annual bonus up to $400,000 if the Company meets or exceeds criteria adopted by the Compensation Committee of the Board of Directors on an annual basis. Effective March 1, 2023, CIE entered into a New Employment Agreement (the “New Agreement”) with the CEO, which superseded the Agreement described above. The initial term of this New Agreement is for a period of two years, and it shall automatically extend for an additional term of one year unless either party gives notice of non-renewal at least six months prior to the expiration of the term then in effect. Under the provisions of this New Agreement, the CEO shall be paid a base salary of $200,000 per annum plus annual cash bonuses and an option to purchase shares of the Company’s common stock in amounts to be determined at the discretion of the Compensation Committee of the Board of Directors. Concurrent with the execution of this New Agreement, the CEO waived all amounts due to him under the previous Agreement totaling $371,600 as of December 31, 2022. As such, the Company wrote-off this accrued balance against compensation expense for the year ended December 31, 2022. See Note 16, Subsequent Events, for additional information regarding this New Agreement.

On April 12, 2021, CIE entered into an Employment Agreement (the “Agreement”) with the Chief Financial Officer (“CFO”) who is also a director, for an initial term of one year with a base salary of $250,000 per annum paid in equal monthly installments, less applicable withholdings and deductions as required by law. The Company is also obligated to increase the base salary on an annual basis between $15,000 and $30,000 at the discretion of the Compensation Committee of the Board of Directors. The CFO is also entitled to receive a car allowance of $1,000 per month and five weeks paid vacation per year. This Agreement automatically extends for additional terms of one year unless either party provides at least six months prior written notice of non-renewal during the initial term or the then current renewal term. In addition, the CFO is entitled to receive a bonus determined by the Compensation Committee of the Board of Directors on an annual basis. Effective March 14, 2023, CIE entered into a New Employment Agreement (the “New Agreement”) with the CFO, which supersedes the Agreement described above. The initial term of this New Agreement is for a period of two years and it shall automatically extend for an additional term of one year unless either party provides notice of non-renewal at least six months prior to the expiration of the term then in effect. Under the provisions of this New Agreement, the CFO shall be paid a base salary of $180,000 per annum plus annual cash bonuses and an option to purchase shares of the Company’s common stock in amounts to be determined at the discretion of the Compensation Committee of the Board of Directors. Concurrent with the execution of this New Agreement, the CFO waived all amounts due to him under the previous Agreement totaling $196,570 as of December 31, 2022. As such, the Company wrote-off this accrued balance against compensation expense for the year ended December 31, 2022.

On February 21, 2022, OXC entered into consulting agreement with an unrelated third-party company and the associated consultant on a non-exclusive basis. Pursuant to terms of the agreement, the consultant company is entitled to receive £15,000 per quarter, plus qualified expenses, until it is terminated by either party giving to the other no less than three months written notice. However, OXC can immediately terminate this agreement, without prejudice, if the consultant commits a material breach or various other forms of misconduct as defined. As additional compensation, the Company’s intends to recommend to the Board of Directors that the consultant be issued a stock grant equal to 3% of the post reorganized shares of CIE’s common stock, when effective, on a fully diluted basis. The Company intends this grant, when issued, will vest over a three-year term at 1% per year as defined. Furthermore, it is the Company’s intention to offer the consultant a seat on the Board of Directors, without compensation. See Note 16, Subsequent Events, for additional information regarding this consulting agreement.

On July 1, 2022, CIE entered into consulting agreement with an individual, who is also a major shareholder of the Company, on a non-exclusive basis. Pursuant to terms of the agreement, the consultant is entitled to receive $15,000 per month, plus qualified expenses, until it is terminated by either party giving to the other no less than three months written notice. However, CIE can immediately terminate this agreement, without prejudice, if the consultant commits a material breach or various other forms of misconduct as defined.

F-16

Table of Contents

(15) Concentration of Credit Risk

The Company maintains cash balances in interest and non-interest-bearing bank accounts which exceed federally insured limits by $222,111 as of September 30, 2023. The Company has not experienced any losses in any of its accounts and management believes not to be exposed to any significant credit risk on cash.

(16) Subsequent Events

Effective October 31, 2023, the unrelated third-party company and associated consultant mutually agreed to terminate the consulting agreement dated February 21, 2022 with OXC without any further obligation between the parties.

Effective November 1, 2023, Andrew Sispoidis resigned from all director, officer, and any other positions and/or roles he had with the Company and each of its wholly-owned subsidiaries, Carbon-Ion and Oxcion, including Chief Executive Officer and Secretary. In addition, the Company, collectively with its wholly-owned subsidiaries CIE and OXC, agreed to pay the former CEO a severance equal to $200,000, payable to him in equal monthly instalments for a period of twelve months following his resignation.

Management has evaluated subsequent events through November 17, 2023, the date these unaudited consolidated financial statements were available to be issued, and has determined that there are o other events that would require an adjustment to, or disclosure in, the unaudited consolidated financial statements as of September 30, 2023.

F-17

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations contain certain forward-looking statements. Historical results may not indicate future performance. Our forward-looking statements reflect our current views about future events; are based on assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements. Factors that may cause differences between actual results and those contemplated by forward-looking statements include, but are not limited to, those discussed in the section titled “Risk Factors” of our Annual Report on Form 10K for the fiscal year ended December 31, 2022 filed on April 17, 2023. We undertake no obligation to publicly update or revise any forward-looking statements, including any changes that might result from any facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements.

Forward-Looking Statements

Some of the statements under “Management's Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” and “would” or the negatives of these terms or other comparable terminology.

You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Quarterly Report on Form 10-Q identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:

	·	The speculative nature of the business we intend to develop;

	·	Our reliance on suppliers and customers;

	·	Our dependence upon external sources for the financing of our operations, particularly given that there are concerns about our ability to continue as a “going concern;”

	·	Our ability to effectively execute our business plan;

	·	Our ability to manage our expansion, growth and operating expenses;

	·	Our ability to finance our businesses;

	·	Our ability to promote our businesses;

	·	Our ability to compete and succeed in highly competitive and evolving businesses;

	·	Our ability to respond and adapt to changes in technology and customer behavior; and

	·	Our ability to protect our intellectual property and to develop, maintain and enhance strong brands.

Page 4 of 13

Table of Contents

Although the forward-looking statements in this Quarterly Report on Form 10-Q are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material and adverse. We undertake no obligation, other than as may be required by law, to update this Quarterly Report on Form 10-Q or otherwise make public statements updating our forward-looking statements.

Organization and Nature of Business

DESCRIPTION OF COMPANY

Based on recent world events, the need for energy security is a top of the geo-political agenda, furthering the need for sustainable, renewable energy. This has been highlighted by the US Government’s recent investment of $30 billion in renewable energy development, which is expected to be replicated by other governments across the world.

Corporate Universe, Inc. (“we,” “us,” “our,” or the “Company” and our wholly-owned subsidiary, Carbon-Ion Energy, Inc. (“Carbon-Ion”) is dedicated to the development of sustainable energy systems based on its proprietary supercapacitor technology.

The Company is positioning itself to lead its chosen markets in the UK and US by 2030 to keep pace with the worldwide goal of carbon-neutrality, initially through the development and deployment in grid services applications.

Carbon-Ion will work collaboratively to become the “go-to” partner in the industry for projects where improved management of power enables the optimization of current and future energy storage and delivery systems across a range of applications, from power grids to transportation.

Carbon Ion is developing next generation supercapacitor technology aimed at the grid and other energy storage applications.

We see both pure supercapacitor and hybrid solutions, by combining the best-in-class battery solutions with supercapacitors, as the way forward to deliver sustainable energy for the next three decades and a grid which is fit for the future. Supercapacitors are different but complimentary technology to batteries.

We are at the beginning of a forecasted once-in-a-century shift in moving away from fossil fuels to power our energy requirements across all demands for electricity. Key to this is the stability of the grid. Energy storage will be key to success in this transition with long, short and medium duration energy stores required to buffer the intermittency of renewable generation. Supercapacitors can not only ensure stable frequency of the grid using short duration pulse power, but also support a lifetime (improving capex and opex) of medium duration storage and provide a bridge to long duration storage which may be slow to start.

Our super capacitor technology has applicability in these large and changing markets, enabling the transition to clean electricity generation without the fluctuations in frequency and supply which are inherent in renewable technologies.

We have spent the last decade developing a proprietary supercapacitor technology to meet these challenges. We believe that our technology enables a new category of supercapacitor that meets the requirements for broader market adoption. The Carbon-ion (C-ion) Supercapacitor technology that we are developing is being designed to offer greater energy density and safety when compared to today’s conventional super capacitors and longer life and faster charging than batteries. Supercapacitors are best used when you need energy fast.

Page 5 of 13

Table of Contents

While current battery technology has demonstrated the benefits of EVs, principally in the premium passenger car market, there are fundamental limitations inhibiting widespread adoption of battery technology. They can catch fire easily, they use rare earth materials and have limited life span and the power delivery is compromised. They are not a universally applicable energy store.

Lamborghini recognized this in their recently launched supercar costing $2.5M the ‘Sian’ that has adopted regenerative braking using super capacitors as their first move to electric powertrains. Supercapacitors can deliver more power, more quickly than a battery solution. As part of the VW Group, Lamborghini elected to go a different route to the rest with their first ever hybrid car, and not follow the industry orthodoxy of a Lithium battery solution. As a result, we believe a hybrid solution using new super capacitor technology with complimentary battery technology represents the most promising path to unlock a mass market shift. A super capacitor can provide that immediate fast delivery (instant kick) mechanism and then once momentum and velocity is achieved the system moves over to battery power. In this way, the system can be better optimized for both cost and performance.

After 30 years of gradual improvements in conventional lithium-ion batteries we believe (like others in the industry) the market needs a step change in battery technology to make mass market EVs competitive with the fossil fuel alternative. We have gone, like Lamborghini’s Terzo Millenio does, down a direct route to achieve this goal.

We will continue developing our C-ion super capacitor technology with the goal of beginning transfer to commercial production in 2026. We have evaluated each of the elements required for initial success and calculated the high performance which we expect from their combination. We are now working to combine and optimize all components of the cell. We will then further develop volume manufacturing processes to enable high volume manufacturing and minimize manufacturing costs.

We are looking to raise funds that will enable us to expand and accelerate research and development activities and undertake additional initiatives. As well as continuing to develop our scientific and engineering capabilities at Milton Park Abingdon England, we will use third party pilot lines, to achieve our goal of being prepared to begin the transition to high volume manufacturing capability from 2026.

We intend to work closely with original equipment manufacturers (“OEMs”) to make our cells widely available over time. We recognize that our supercapacitor technology has applicability in other large and growing markets including energy storage and other electricity grid type environments such as frequency response. We expect that the heavy transport industries such as shipping, trains, planes and nascent charging infrastructure will also be featured.

Our technology enables a variety of business models. In addition to joint ventures, we may look to operate solely-owned manufacturing facilities or license technology to other manufacturers. Where appropriate, we may sell know how, electrodes or other subassemblies rather than complete super capacitor cells. We intend to continue to invest in research and development beyond Gen 4.0 to improve super capacitor cell performance, improve manufacturing processes, and reduce cost subject to having raised sufficient funds to do this.

Carbon-Ion was founded to develop a new class of energy storage device with considerable functional improvements over commercially available supercapacitors.

The C-Ion cell will provide specific power characteristics much higher than a typical Li-ion cell. It is designed to be classified as non-flammable and non-hazardous for transport, allowing the product to be shipped easily and to comply with both current and future regulations.

Page 6 of 13

Table of Contents

Due to the method of energy storage, the cell has fewer moving parts electrochemically and can go through significantly more charge/discharge cycles and/or operate for many years of normal use.

The C-Ion cell is being designed for manufacture using technologies well known in high volume manufacture. This will enable Carbon-Ion to quickly scale-up production. Carbon-ion allows new products to be made and extra functions to be added to existing products, for example:

	·	Improved energy storage allows the cell to be used as the principal method of energy storage in a far wider range of technologies than conventional supercapacitors

	·	High specific power allows very fast charging

	·	High specific power enables the extension of Li-ion battery lifetimes and reduction in battery size through peak shaving in hybrid applications

	·	Improved safety protects customers, allows easy shipping and opens up applications in hazardous areas

	·	Long cycle life allows energy storage to be installed for the entire lifetime of the device, reducing design complexity, eliminating service intervals and saving money

Results of Operations

Three Months Ended September 30, 2023 Compared to the Three Months Ended September 30, 2022

Revenues

Revenues for the three months ended September 30, 2023 were $0 as compared with $0 for the comparable prior year period, a change of $0, or 0%. The lack of revenue is due to the fact that the Company did not generate any sales for the three months ended September 30, 2023 and 2022 from its supercapacitor technology.

Operating Expenses

Operating expenses for the three months ended September 30, 2023 were $434,522 as compared to $672,539 for the comparable prior year period, a decrease of $238,017, or approximately 35%. This change in operating expenses resulted primarily from a $112,812 decrease in salaries, wages, and payroll taxes primarily attributable to adjustments of officers’ salaries for cost containment purposes plus a decrease of $119,569 in legal and professional fees primarily attributable to the patents.

Net Operating Loss

Our net operating loss for the three months ended September 30, 2023 was $434,522 as compared with a net operating loss of $672,539 for the comparable prior year period, a decrease of $238,017, or approximately 35%. This change in net operating loss is directly due to the change in operating expenses recorded in the current period compared to the comparable prior year period as described in the caption immediately above.

Other Income (Expenses)

Other expenses for the three months ended September 30, 2023 was $405,613 as compared with $34,998 for the comparable prior year period, an overall increase of $370,615. That change resulted primarily from an increase of $357,681 in interest expense attributable to increased borrowings to fund operations.

Net Loss

Our net loss for the three months ended September 30, 2023 was $784,466 as compared with a net loss of $651,136 for the comparable prior year period, an increase of $133,330, or approximately 20%. The increase in net loss is primarily related to the $238,017 benefit of the decrease in the net operating loss offset by the $370,615 increase in other expenses as described in the captions above.

Comprehensive Loss

Our comprehensive loss for the three months ended September 30, 2023 was $785,898 as compared with a loss of $651,271 for the comparable prior year period, a increase of $134,627, or approximately 21%. This increase in comprehensive loss is comprised primarily of the increase in net loss of $133,330 described immediately above.

Page 7 of 13

Table of Contents

Nine Months Ended September 30, 2023 Compared to the Nine Months Ended September 30, 2022

Revenues

Revenues for the nine months ended September 30, 2023 were $0 as compared with $0 for the comparable prior year period, a change of $0, or 0%. The lack of revenue is due to the fact that the Company did not generate any sales for the nine months ended September 30, 2023 and 2022 from its supercapacitor technology.

Operating Expenses

Operating expenses for the nine months ended September 30, 2023 were $1,591,772 as compared with $2,191,708 for the comparable prior year period, a decrease of $599,936, or approximately 27%. This change in operating expenses resulted primarily from a $343,255 decrease in salaries, wages, and payroll taxes primarily attributable to adjustments of officers’ salaries for cost containment purposes plus a decrease of $240,493 in legal and professional fees primarily attributable to the patents.

Net Operating Loss

Our net operating loss for the nine months ended September 30, 2023 was $1,591,772 as compared with a net operating loss of $2,191,708 for the comparable prior year period, a decrease of $599,936, or approximately 27%. This change in net operating loss is directly due to the change in operating expenses recorded in the current period compared to the comparable prior year period as described in the caption immediately above.

Other Income (Expenses)

Other expenses for the nine months ended September 30, 2023 was $803,718 as compared with $44,093 for the comparable prior year period, an overall increase of $759,625. That change consisted of an increase of $673,490 in interest expense attributable to increased borrowings to fund operations and an expense of $85,938 attributable to the establishment of a reserve for impairment of certain intellectual property.

Net Loss

Our net loss for the nine months ended September 30, 2023 was $2,218,072 as compared with a net loss of $1,997,087 for the comparable prior year period, an increase of $220,985, or approximately 11%. The increase in net loss is primarily related to the benefit of a $599,936 decrease in operating expenses offset by an increase of $759,625 in other income/expenses as described in the captions above.

Comprehensive Loss

Our comprehensive loss for the nine months ended September 30, 2023 was $2,335,659 as compared with a loss of $2,134,528 for the comparable prior year period, an increase of $201,131 or approximately 9%. This increase in comprehensive loss is comprised of an increase in net loss of $220,985 described above offset by a favorable change of $19,854 in the foreign currency translation adjustment which is attributable to changes in exchange rates.

Current Liquidity and Capital Resources for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022

	2023			2022
Summary of Cash Flows:

Net cash used in operating activities	$	(2,201,834	)	$	(1,031,840	)
Net cash used in investing activities		(80,442	)		(647,444	)
Net cash provided by financing activities		2,327,735			2,086,406
Effect of exchange rate changes on cash		(33,999	)		(316,012	)
Net increase in cash and cash equivalents		11,460			91,110
Beginning cash and cash equivalents		464,227			3,208
Ending cash and cash equivalents	$	475,687		$	94,318

Page 8 of 13

Table of Contents

Operating Activities

Net cash used in operations of $2,201,834 during the nine months ended September 30, 2023 was primarily the result of our $2,218,072 net loss plus $524,728 in amortization of notes payable discounts, plus $109,725 for changes in the landlord buildout receivable, less $174,187 for changes in income tax credits receivable, less $185,059 for changes in accounts payable and accrued expenses, and less $236,676 for changes in payroll taxes payable.

Net cash used in operations of $1,031,840 during the nine months ended September 30, 2022 was primarily the result of our $1,997,087 net loss less $402,614 for changes in income tax credits receivable, less $296,088 for changes in accounts payable and accrued expenses, and less $153,981 for changes in payroll taxes payable.

Investing Activities

Net cash used in investing activities of $80,442 for the nine months ended September 30, 2023 consisted of $53,413 for additions to intellectual property and $27,029 for acquisition of property and equipment.

Net cash used in investing activities of $647,444 for the nine months ended September 30, 2022 consisted of $47,454 for additions to intellectual property and $599,900 for acquisition of property and equipment.

Financing Activities

Net cash provided by financing activities of $2,327,735 during nine months ended September 30, 2023 consisted primarily of $1,124,375 in proceeds from the sale of common stock and $999,375 in proceeds from the issuance of notes payable.

Net cash provided by financing activities of $2,086,406 during nine months ended September 30, 2022 consisted primarily of $1,182,000 in proceeds from the sale of common stock and $479,961 in proceeds from the issuance of notes payable.

Future Capital Requirements

Our current available cash and cash equivalents are insufficient to satisfy our liquidity requirements. Our capital requirements through the end of fiscal year 2023 and into fiscal year 2024 will depend on numerous factors, including management’s evaluation of the timing of projects to pursue. Subject to our ability to generate revenues and cash flow from operations and our ability to raise additional capital (including through possible joint ventures and/or partnerships), we expect to incur substantial expenditures to carry out our business plan, as well as costs associated with our capital raising efforts and being a public company.

Our plans to finance our operations include seeking equity and debt financing, alliances or other partnership agreements, or other business transactions, that would generate sufficient resources to ensure continuation of our operations.

The sale of additional equity or debt securities may result in additional dilution to our shareholders. If we raise additional funds through the issuance of debt securities or preferred stock, these securities could have rights senior to those of our common stock and could contain covenants that would restrict our operations. Any such required additional capital may not be available on reasonable terms, if at all. If we were unable to obtain additional financing, we may be required to reduce the scope of, delay or eliminate some or all of our planned activities and limit our operations which could have a material adverse effect on our business, financial condition and results of operations.

Inflation

The amounts presented in our unaudited consolidated financial statements do not provide for the effect of inflation on our operations or financial position. The net operating losses shown would be greater than reported if the effects of inflation were reflected either by charging operations with amounts that represent replacement costs or by using other inflation adjustments.

Page 9 of 13

Table of Contents

Going Concern

The accompanying unaudited consolidated financial statements have been prepared on a going concern basis. For the nine months ended September 30, 2023 and as of that balance sheet date, the Company had a net loss of $2,218,072, net cash used in operating activities of $2,201,834, negative working capital of $4,064,987, an accumulated operating deficit of $7,350,085, and a stockholders’ deficit of $2,569,228. These matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, to fund possible future acquisitions, and to generate profitable operations in the future. Management plans to provide for the Company’s capital requirements by continuing to issue additional equity and debt securities. The outcome of these matters cannot be predicted at this time and there are no assurances that, if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results. The unaudited consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Quantitative and Qualitative Disclosures about Market Risk

In the ordinary course of our business, we are not exposed to market risk of the sort that may arise from changes in interest rates or foreign currency exchange rates, or that may otherwise arise from transactions in derivatives.

The preparation of financial statements in conformity with GAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our significant estimates and assumptions include the fair value of our common stock, stock-based compensation, the recoverability and useful lives of long-lived assets, and the valuation allowance relating to our deferred tax assets.

Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. Our management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we, in consultation with legal counsel, evaluate the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in our financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is probable, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, the Company has elected not to provide the disclosure required by this item.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Our management is responsible for maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that the Registrant files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. In addition, the disclosure controls and procedures must ensure that such information is accumulated and communicated to the Registrant's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.

Page 10 of 13

Table of Contents

As of September 30, 2023, an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Exchange Act) was carried out under the supervision and with the participation of Andrew Sispoidis our Chief Executive Officer (until November 1, 2023), Jack Brooks our President and Principal Executive Officer and Adrian Jones our Chief Financial Officer. Based on his evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that as of September 30, 2023, our disclosure controls and procedures are not effective due to material weaknesses in our internal controls over financial reporting.

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP.

Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; (iii) provide reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and (iv) provide reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because changes in conditions may occur or the degree of compliance with the policies or procedures may deteriorate.

Our management has conducted an evaluation, under the supervision and with the participation of Andrew Sispoidis, Chief Executive Officer (until November 1, 2023), Jack Brooks, President and Adrian Jones, Chief Financial Officer of the effectiveness of our internal control over financial reporting as of September 30, 2023. This evaluation was based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, Internal Control-Integrated Framework.

This Report shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

This quarterly report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. The rules of the Securities and Exchange Commission do not require an attestation of the Management's report by our registered public accounting firm in this quarterly report.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting, as defined in Rules 13a-15(f) of the Exchange Act, during the Company’s most recent fiscal quarter ended September 30, 2023, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Page 11 of 13

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

Please see Item 3 to our Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC on April 17, 2023, (the “Annual Report”) for a description of pending litigation. There have been no additional developments or updates from the Annual Report.

Item 1A. Risk Factors

Risk factors that affect our business and financial results are discussed in Part I, Item 1A “Risk Factors,” in our Annual Report. There have been no material changes in our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks described in our Annual Report, which could materially affect our business, financial condition or future results. The risks described in our Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

On August 2, 2023, in connection with the consummation of that certain Contribution and Exchange Agreement dated as of August 2, 2023 between Corporate Universe, Inc. and its wholly-owned subsidiary Carbon-Ion Energy, Inc., our board of directors approved a plan of liquidation. This plan of liquidation remains subject to stockholder approval.

Item 6. Exhibits

SEC Ref. No.				Title of Document
31.1*				Rule 13a-14(a) Certification by Principal Executive Officer
31.2*				Rule 13a-14(a) Certification by Principal Financial Officer
32.1**				Section 1350 Certification of Principal Executive Officer
32.2**				Section 1350 Certification of Principal Financial Officer
101.INS*				XBRL Instance Document
101.SCH*				XBRL Taxonomy Extension Schema Document
101.CAL*				XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*				XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*				XBRL Taxonomy Extension Label Linkbase Document
101.PRE*				XBRL Taxonomy Extension Presentation Linkbase Document

__________________

*Filed with this Report.

**Furnished with this Report.

Page 12 of 13

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Corporate Universe, Inc.

Date: November 17, 2023	By:	/s/ Jack Brooks
		Jack Brooks, President
		(Principal Executive Officer)

Date: November 17, 2023	By:	/s/ Adrian Jones
		Adrian Jones, Chief Financial Officer
		(Principal Financial and Accounting Officer)

Page 13 of 13